Yatharth Hospital gets SEBI green signal to launch Rs 610 crore IPO

In Sebi's parlance, issuing an observation letter implies its go-ahead to float an IPO.

Published On 2022-08-09 06:23 GMT   |   Update On 2022-08-09 06:23 GMT
Advertisement

New Delhi: Yatharth Hospital & Trauma Care Services Ltd has received capital markets regulator Sebi's go ahead to float an initial public offering (IPO).

The company operates three super specialty hospitals in Delhi-NCR. It recently expanded to Madhya Pradesh.

Yatharth Hospital's IPO consists of a fresh issue of equity shares aggregating up to Rs 610 crore and an Offer For Sale (OFS) offer for sale of up to 65.51 lakh equity shares by the company's promoters and promoter group entities, according to the draft red herring prospectus (DRHP).

Read also: PharmEasy parent API Holdings and 2 others get SEBI go-ahead to float IPOs

The company, which filed its preliminary IPO papers with the capital markets regulator in April, obtained its "observation" letter on August 2, an update with the Securities and Exchange Board of India (Sebi) showed.

In Sebi's parlance, issuing an observation letter implies its go-ahead to float an IPO.

Read also: Macleods Pharma and 2 others get SEBI go ahead for IPOs

Going by the draft papers, the firm intends to utilise the net proceeds for payment of debt, funding capital expenditure expenses, funding inorganic growth initiatives through acquisition and other strategic initiatives, and for general corporate purposes.

Intensive Fiscal Services Pvt Ltd, Ambit Pvt Ltd and IIFL Securities Ltd are the book-running lead managers for the IPO.

Read also: Innova Captab files IPO papers with SEBI


Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News